SCHEMBL4992871

SCHEMBL4992871

OCCN1C=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7072086 0.86
SCHEMBL10542818 0.78 KDM4E (0.33)
Hydrochloric Acid SCHEMBL3237965 0.77
SCHEMBL4721663 0.75
SCHEMBL1193464 0.75
SCHEMBL5204363 0.70
SCHEMBL15047584 0.70
SCHEMBL9244035 0.70
SCHEMBL19599281 0.67
SCHEMBL3816759 0.67 AGL (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0304552-A1 Heterocyclic hydroxyazoles BAYER AG (DE) 1989-03-01 EP claimed
EP-0011769-B1 HYDROXYETHYL AZOLES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS BAYER AG (DE) 1982-04-14 EP claimed
EP-0017080-A2 Process for the preparation of hydroxyethyl azoles; intermediates BAYER AG (DE) 1980-10-15 EP claimed
EP-0011769-A1 Hydroxyethyl azoles, process for their preparation and their use in medicaments BAYER AG (DE) 1980-06-11 EP claimed
CN-119548497-A Method for treating myopia by using vinpocetine 温州医科大学附属眼视光医院 2025-03-04 CN disclosed
CN-119061713-A Recording method and composition set 精工爱普生株式会社 2024-12-03 CN disclosed
CN-118634218-A Pharmaceutical composition for effectively delaying and treating myopia 温州医科大学附属眼视光医院 2024-09-13 CN disclosed
US-20240165089-A1 METHOD FOR TREATING MYOPIA WITH VINPOCETINE Eye Hospital, Wenzhou Medical University (CN) 2024-05-23 US disclosed
EP-4364736-A1 METHOD FOR TREATING MYOPIA WITH VINPOCETINE The Eye Hospital of Wenzhou Medical University (CN) 2024-05-08 EP disclosed
CN-113015526-A Spirocyclic 2, 3-dihydro-7-azaindole compounds and uses thereof 豪夫迈·罗氏有限公司 2021-06-22 CN disclosed
US-20150112051-A1 CONSTRUCTION OF CELL PENETRATING NUCLEIC ACIDS Panzner, Steffen 2015-04-23 US disclosed
US-20150112051-A1 CONSTRUCTION OF CELL PENETRATING NUCLEIC ACIDS Panzner, Steffen 2015-04-23 US disclosed
US-20030199478-A1 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN, INC. 2003-10-23 US disclosed
WO-2003027102-A1 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2003-04-03 WO disclosed
EP-0304552-A1 Heterocyclic hydroxyazoles BAYER AG (DE) 1989-03-01 EP disclosed
EP-0304552-A1 Heterocyclic hydroxyazoles BAYER AG (DE) 1989-03-01 EP disclosed
EP-0017080-A3 PROCESS FOR THE PREPARATION OF HYDROXYETHYL AZOLES; INTERMEDIATES BAYER AG (DE) 1981-01-14 EP disclosed
EP-0017080-A2 Process for the preparation of hydroxyethyl azoles; intermediates BAYER AG (DE) 1980-10-15 EP disclosed
EP-0017080-A2 Process for the preparation of hydroxyethyl azoles; intermediates BAYER AG (DE) 1980-10-15 EP disclosed
EP-0011769-A1 Hydroxyethyl azoles, process for their preparation and their use in medicaments BAYER AG (DE) 1980-06-11 EP disclosed